HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heyu Ni Selected Research

Fibronectins (Fibronectin)

5/2016Extracellular matrix proteins in the regulation of thrombus formation.
1/2016Fibronectin maintains the balance between hemostasis and thrombosis.
10/2015Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis.
8/2015Fibronectin orchestrates thrombosis and hemostasis.
10/2014Plasma fibronectin supports hemostasis and regulates thrombosis.
2/2009Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.
11/2003Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain.
3/2003Plasma fibronectin promotes thrombus growth and stability in injured arterioles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heyu Ni Research Topics

Disease

43Thrombosis (Thrombus)
04/2022 - 03/2003
32Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
05/2021 - 04/2006
27Hemorrhage
04/2022 - 04/2006
26Thrombocytopenia (Thrombopenia)
11/2021 - 01/2006
7Neonatal Alloimmune Thrombocytopenia
11/2021 - 04/2006
4Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 01/2012
4Autoimmune Diseases (Autoimmune Disease)
01/2021 - 10/2012
4Atherosclerosis
10/2020 - 06/2011
4Infections
07/2020 - 01/2012
4Vascular System Injuries
01/2020 - 01/2007
3Neoplasms (Cancer)
07/2020 - 01/2018
2Wounds and Injuries (Trauma)
01/2021 - 10/2019
2Stroke (Strokes)
10/2020 - 01/2018
2Myocardial Infarction
10/2020 - 01/2018
2Inflammation (Inflammations)
07/2020 - 07/2009
2Pathologic Processes
01/2020 - 01/2016
2Spontaneous Abortion (Miscarriage)
01/2017 - 11/2011
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
10/2016 - 02/2016
2Cytopenia
07/2015 - 04/2006
2Necrosis
05/2015 - 11/2011
2Hypercholesterolemia
11/2014 - 05/2013
1Thromboinflammation
04/2022
1Ischemic Stroke
04/2022
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
12/2021
1Carotid Stenosis (Carotid Artery Stenosis)
12/2021
1Heart Diseases (Heart Disease)
12/2021
1Vascular Diseases (Vascular Disease)
12/2021
1Fetal Death
11/2021
1Disseminated Intravascular Coagulation
11/2021
1Bernard-Soulier Syndrome (Giant Platelet Syndrome)
05/2021
1Hemolysis
01/2021
1Hypersensitivity (Allergy)
01/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2020
1Thrombotic Microangiopathies
07/2020
1Hemophilia A (Haemophilia)
07/2020
1Sarcoma (Soft Tissue Sarcoma)
01/2020

Drug/Important Bio-Agent (IBA)

27Inosine Triphosphate (ITP)IBA
05/2021 - 04/2006
17AntibodiesIBA
11/2021 - 04/2006
14Fibrinogen (Factor I)FDA Link
01/2020 - 03/2003
13IntegrinsIBA
01/2020 - 06/2003
8Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2011
8AutoantibodiesIBA
01/2021 - 02/2012
8LigandsIBA
01/2018 - 03/2003
8Fibronectins (Fibronectin)IBA
05/2016 - 03/2003
7von Willebrand FactorIBA
01/2021 - 03/2003
7AntigensIBA
01/2020 - 04/2006
6Intravenous Immunoglobulins (IVIG)FDA Link
11/2021 - 04/2006
5FibrinIBA
05/2016 - 11/2003
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2021 - 01/2018
4Hemostatics (Antihemorrhagics)IBA
01/2021 - 01/2007
4CollagenIBA
01/2021 - 02/2009
4Anthocyanins (Anthocyanin)IBA
10/2017 - 06/2011
4Immunoglobulin G (IgG)IBA
03/2013 - 04/2006
3ThrombinFDA Link
01/2021 - 01/2007
3ferric chlorideIBA
01/2021 - 01/2007
3Neuraminidase (Sialidase)IBA
07/2015 - 01/2015
3Glycoproteins (Glycoprotein)IBA
04/2015 - 04/2006
2C-Type Lectins (C-Type Lectin)IBA
11/2021 - 01/2012
2Platelet Membrane GlycoproteinsIBA
05/2021 - 02/2016
2Agkistrodon acutus agkisacucetin proteinIBA
01/2021 - 02/2014
2multimerinIBA
01/2021 - 05/2010
2AnticoagulantsIBA
07/2020 - 10/2014
2coenzyme Q10 (CoQ10)IBA
01/2020 - 12/2019
2Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2015
2IsoantibodiesIBA
01/2017 - 06/2015
2Integrin beta3 (GPIIIa)IBA
10/2016 - 04/2006
2Extracellular Matrix ProteinsIBA
05/2016 - 01/2016
2Exenatide (Byetta)FDA Link
01/2016 - 09/2011
2SteroidsIBA
07/2015 - 02/2012
2LipopolysaccharidesIBA
12/2013 - 01/2006
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2012 - 01/2006
2Monoclonal AntibodiesIBA
02/2009 - 08/2006
1CarrageenanIBA
04/2022
1CoagulantsIBA
04/2022
1KininsIBA
04/2022
1Viper Venoms (Viper Venom)IBA
11/2021
1Antivenins (Antivenoms)IBA
11/2021
1Snake Venoms (Snake Venom)IBA
11/2021
1VenomsIBA
11/2021
1daidzeinIBA
08/2021
1GenisteinIBA
08/2021
1Fibrillar CollagensIBA
01/2021
1RistocetinIBA
01/2021
1TantalumIBA
01/2021
1HLA-G Antigens (HLA G)IBA
01/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2021
1botrocetinIBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1TicagrelorIBA
10/2020
1Factor V (Coagulation Factor V)IBA
07/2020
1Myosin Light Chains (Myosin Essential Light Chain)IBA
01/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020
1IsomerasesIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1Biological ProductsIBA
01/2020
1Cell Surface ReceptorsIBA
01/2020
1Sulfhydryl Compounds (Thiols)IBA
01/2020

Therapy/Procedure

18Therapeutics
12/2021 - 04/2006
4Lasers (Laser)
10/2019 - 02/2014
3Platelet Transfusion (Blood Platelet Transfusions)
09/2018 - 12/2013